291 related articles for article (PubMed ID: 29723940)
1. [Intradermal immunotherapy with low-dose house dust mite allergens in patients with allergic rhinitis: A proof-of-concept study].
Vieira-Hernández A; Capriles-Hulett A; Sánchez-Borges M; Fabiano F; Albarrán-Barrios C
Rev Alerg Mex; 2018; 65(1):41-51. PubMed ID: 29723940
[TBL] [Abstract][Full Text] [Related]
2. Aqueous intradermal low-dose house dust mite immunotherapy in tropical settings: a valid cost-effective approach for developing nations?
Rondon C; Sánchez-Borges M; Cupello ER; Fabiano F; Capriles-Hulett A
Allergol Immunopathol (Madr); 2021; 49(2):31-39. PubMed ID: 33641291
[TBL] [Abstract][Full Text] [Related]
3. Clinical Response to Subcutaneous Dermatophagoides pteronyssinus Immunotherapy in Children with Allergic Rhinitis and Asthma Is Independent of Sensitization to Blomia tropicalis Allergens.
Chen S; Zheng Y; Chen B; Zhong H; Liao F; Wang L; Hui SF; Lai X
Int Arch Allergy Immunol; 2019; 178(2):201-210. PubMed ID: 30544116
[TBL] [Abstract][Full Text] [Related]
4. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
[TBL] [Abstract][Full Text] [Related]
5. The changes in different symptom scores during subcutaneous immunotherapy in Chinese house dust mite allergic patients: a two-year, observational study.
Tu Y; Zhang H; Zhao L; Jin P; Zi X; Li T; Shi L; Zhi L
J Laryngol Otol; 2019 Mar; 133(3):213-219. PubMed ID: 30674357
[TBL] [Abstract][Full Text] [Related]
6. Long-term efficacy of standardised specific subcutaneous immunotherapy in children with persistent allergic rhinitis due to multiple allergens including house dust mites.
Song Y; Long J; Wang T; Xie J; Wang M; Tan G
J Laryngol Otol; 2018 Mar; 132(3):230-235. PubMed ID: 29374499
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of allergen-specific subcutaneous immunotherapy for house dust mite induced allergic rhinitis.
Sahin E; Dizdar D; Dinc ME; Cirik AA
J Laryngol Otol; 2017 Nov; 131(11):997-1001. PubMed ID: 29037263
[TBL] [Abstract][Full Text] [Related]
8. The efficacy and safety of two commercial house dust mite extracts for allergic rhinitis: a head-to-head study.
Li J; Wu Y; Yang Y; Huang N; Li W; Zhang S; Jiang Q; Yang L; Zhu R
Int Forum Allergy Rhinol; 2019 Aug; 9(8):876-882. PubMed ID: 31322838
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy evaluation of specific immunotherapy with standardized house dust mite allergen preparation for allergic rhinitis].
Zhou J; He Y; Zeng X; Li Z; Pan F; Chen Y; Li Z
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Jun; 26(11):487-9. PubMed ID: 22934334
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of subcutaneous house dust mite immunotherapy in patients with moderate to severe allergic rhinitis.
Valero A; Ibáñez-Echevarría E; Vidal C; Raducan I; Castelló Carrascosa JV; Sánchez-López J
Immunotherapy; 2022 Jun; 14(9):683-694. PubMed ID: 35465692
[TBL] [Abstract][Full Text] [Related]
11. Absence of IgE neosensitization in house dust mite allergic patients following sublingual immunotherapy.
Baron-Bodo V; Batard T; Nguyen H; Fréreux M; Horiot S; Harwanegg C; Bergmann KC; de Beaumont O; Moingeon P
Clin Exp Allergy; 2012 Oct; 42(10):1510-8. PubMed ID: 22994348
[TBL] [Abstract][Full Text] [Related]
12. The Functional IgE-Blocking Factor Induced by Allergen-Specific Immunotherapy Correlates with IgG4 Antibodies and a Decrease of Symptoms in House Dust Mite-Allergic Children.
Zhao D; Lai X; Tian M; Jiang Y; Zheng Y; Gjesing B; Zhong N; Spangfort MD
Int Arch Allergy Immunol; 2016; 169(2):113-20. PubMed ID: 27049773
[TBL] [Abstract][Full Text] [Related]
13. Epicutaneous Allergen Administration with Microneedles as a Novel Method of Immunotherapy for House Dust Mite (HDM) Allergic Rhinitis.
Choi YJ; Kim KA; Jung JH; Choi YS; Baek SK; Kim ST; Park JH
Pharm Res; 2021 Jul; 38(7):1199-1207. PubMed ID: 34145532
[TBL] [Abstract][Full Text] [Related]
14. [The efficacy of sublingual specific immunotherapy in children with allergic rhinitis].
Li P; Fa M; Huang ZH; Xie LS; Xu Y; Chen WB; Zhang JY; Zhang XR; Zhu Z; Li Q
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 30(7):546-551. PubMed ID: 29871066
[No Abstract] [Full Text] [Related]
15. [Skin prick tests with standardized extracts of mites of different precedence in patients with asthma and allergic rhinitis].
Rodríguez Santos O; Abou Khair F; Tinoco Morán IO; Celio Murillo R; Meli VR; Barata HJ; Labrada Rosado A
Rev Alerg Mex; 2010; 57(6):196-201. PubMed ID: 21944487
[TBL] [Abstract][Full Text] [Related]
16. House Dust Mite Sublingual Immunotherapy for Pediatric Patients With Allergic Asthma.
Richards JR; Stumpf JL
Ann Pharmacother; 2018 Oct; 52(10):1019-1030. PubMed ID: 29642713
[TBL] [Abstract][Full Text] [Related]
17. A Three-Year Course of House Dust Mite Sublingual Immunotherapy Appears Effective in Controlling the Symptoms of Allergic Rhinitis.
Novakova SM; Novakova PI; Yakovliev PH; Staevska MT; Mateva NG; Dimcheva TD; Peichev JL
Am J Rhinol Allergy; 2018 May; 32(3):147-152. PubMed ID: 29649893
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of the SQ house dust mite sublingual immunotherapy tablet in Japanese adults and adolescents with house dust mite-induced allergic rhinitis.
Okubo K; Masuyama K; Imai T; Okamiya K; Stage BS; Seitzberg D; Konno A
J Allergy Clin Immunol; 2017 Jun; 139(6):1840-1848.e10. PubMed ID: 27864024
[TBL] [Abstract][Full Text] [Related]
19. Depigmented and polymerised house dust mite allergoid: allergen content, induction of IgG4 and clinical response.
Gallego MT; Iraola V; Himly M; Robinson DS; Badiola C; García-Robaina JC; Briza P; Carnés J
Int Arch Allergy Immunol; 2010; 153(1):61-9. PubMed ID: 20357486
[TBL] [Abstract][Full Text] [Related]
20. Salivary Immunoglobulin A, E, and G4 Levels Specific to Dermatophagoides pteronyssinus in Allergic Rhinitis Patients Treated With Subcutaneous Immunotherapy.
Liu Y; Xing Z; Wang J; Geng C
Am J Rhinol Allergy; 2018 Nov; 32(6):458-464. PubMed ID: 30124065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]